Spondylometaphyseal dysplasia, Sedaghatian type

From WikiMD's Wellness Encyclopedia

Spondylometaphyseal Dysplasia, Sedaghatian Type is a rare genetic disorder that affects the development of the bones, particularly those in the spine (spondylo) and the metaphyses of the long bones. This condition is part of a group of disorders known as skeletal dysplasias, which are characterized by abnormalities in the size and shape of the spine and limbs. Spondylometaphyseal Dysplasia, Sedaghatian Type, is distinguished by its specific skeletal abnormalities, as well as potential complications involving the heart and metabolic system.

Symptoms and Characteristics[edit | edit source]

Individuals with Spondylometaphyseal Dysplasia, Sedaghatian Type, typically present with a short stature, short trunk, and abnormalities in the metaphyses (the wide portion at the end of long bones) and the vertebrae. Other common features may include:

In addition to skeletal abnormalities, some individuals may experience cardiac issues, such as cardiomyopathy (disease of the heart muscle), and metabolic problems, including hypoglycemia (low blood sugar levels).

Causes[edit | edit source]

Spondylometaphyseal Dysplasia, Sedaghatian Type, is caused by genetic mutations. The exact gene(s) responsible for this condition have not been definitively identified, making the inheritance pattern unclear. However, it is believed to be inherited in an autosomal recessive manner, meaning that an individual must receive a mutated gene from both parents to be affected.

Diagnosis[edit | edit source]

Diagnosis of Spondylometaphyseal Dysplasia, Sedaghatian Type, is primarily based on the clinical presentation and radiographic findings. X-rays and other imaging techniques are used to assess the characteristic skeletal abnormalities. Genetic testing may also be employed to identify specific mutations, although the causative gene(s) may not always be known.

Treatment[edit | edit source]

There is no cure for Spondylometaphyseal Dysplasia, Sedaghatian Type, and treatment is focused on managing symptoms and improving quality of life. This may include:

  • Orthopedic interventions to address skeletal deformities
  • Physical therapy to enhance mobility
  • Management of cardiac and metabolic issues as they arise

Prognosis[edit | edit source]

The prognosis for individuals with Spondylometaphyseal Dysplasia, Sedaghatian Type, varies depending on the severity of symptoms and the presence of complications, such as cardiac issues. Early intervention and comprehensive care can help manage symptoms and improve outcomes.

Spondylometaphyseal dysplasia, Sedaghatian type Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD